http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9871299

Outgoing Links

Predicate Object
contentType Clinical Trial|Letter
endingPage 390
issn 1432-2072
0033-3158
issueIdentifier 3
pageRange 389-390
publicationName Psychopharmacology
startingPage 389
bibliographicCitation de Haan L, van Amelsvoort T, Rosien K, Linszen D. Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets. Psychopharmacology (Berl). 2004 Sep;175(3):389–90. doi: 10.1007/s00213-004-1951-2. PMID: 15322727.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd0c509142036884fa5d1e3c1a4886d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f3a0390851539ea2e74dba4ce284d39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4953321ae921e80bfd1c49d93dcfdc6d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4616810529a91fcdea5f0ed5ba43a775
date 2004-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s00213-004-1951-2
https://pubmed.ncbi.nlm.nih.gov/15322727
isPartOf https://portal.issn.org/resource/ISSN/0033-3158
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6790
https://portal.issn.org/resource/ISSN/1432-2072
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets
discusses http://id.nlm.nih.gov/mesh/M0020993
http://id.nlm.nih.gov/mesh/M0026372
http://id.nlm.nih.gov/mesh/M0002356
http://id.nlm.nih.gov/mesh/M0204623
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128442098

Total number of triples: 32.